Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC479

Glofitamab

  • Status:
    Veitt
  • Application date:
    23.8.2024
  • Application published:
    15.9.2024
  • Grant published:
    15.12.2025
  • Max expiry date:
    9.7.2038
  • Medicine name:
    Columvi
  • Medicine for children:
    No

Timeline

Today
23.8.2024Application
15.9.2024Publication
15.12.2025Registration
9.7.2038Expires

Marketing license

  • IS authorization number:
    EU/1/23/1742
  • Date:
    9.8.2023
  • Foreign authorization number:
    EU/1/23/1742
  • Date:
    7.7.2023

Owner

  • Name:
    F. Hoffmann-La Roche AG
  • Address:
    Grenzacherstrasse 124, 4070 Basel CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 22.11.2025

Upload documents